Clin2
NCT07479134Possibly a fitRecruiting

Producing stem cells for pancreatic cell research

Diabetes

Part of Hormones & metabolism clinical trials.

This study collects skin or blood samples to create stem cells that can be turned into insulin-producing pancreatic cells. It may help people with diabetes and other beta cell disorders by providing cells for future research or treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
12 years to 70 years
Study type
Interventional

Who can take part

  • You are between 12 and 70 years old.
  • You either have a pancreatic beta cell condition (like type 1 or 2 diabetes, MODY, Wolfram syndrome) OR you are a healthy volunteer.
  • You are able to give consent (or have a parent/guardian do so).
  • You do not have active cancer, HIV, hepatitis B or C.
  • You are not taking strong steroids or immune-suppressing drugs (unless approved by study doctors).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06751199Recruiting
Stem cells combined with islet transplant for diabetes

This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.

Shanghai, Shanghai Municipality
NCT07695727Not yet recruiting
Studying a sugar protein to understand type 1 diabetes

This study is looking at how a sugar-processing protein, called GLUT1, affects the immune system in people with type 1 diabetes. It uses blood samples already stored in a biobank, so no new samples or treatments are needed from you.

Milan
NCT06938334Not yet recruiting· Phase 1/Phase 2
Gene therapy with stem cells for early type 1 diabetes

This trial tests an experimental gene therapy using your own stem cells to treat early type 1 diabetes. It aims to preserve insulin-making cells and potentially reduce your need for insulin.

Padova, Italia
NCT04011020Recruiting· Phase 3
Stem cell treatment for type 1 diabetes

This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.

Paramus, New Jersey
NCT07464119Not yet recruiting
Lab-made insulin cells for diabetes treatment

This trial studies a new treatment made from special cells that can make insulin for people with diabetes. The goal is to see if these cells can help control blood sugar and reduce the need for insulin injections.

Beijing
NCT07503028Enrolling by invitation· Early Phase 1
Stem cell therapy for severe low blood sugar in diabetes

This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.

Hefei, Anhui

Hear when a new Diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.